Senese Rosalba, Cioffi Federica, de Lange Pieter, Leanza Cristina, Iannucci Liliana F, Silvestri Elena, Moreno Maria, Lombardi Assunta, Goglia Fernando, Lanni Antonia
Dipartimento di Scienze e Tecnologie Ambientali, Biologiche e Farmaceutiche, Università degli Studi della Campania, "Luigi Vanvitelli" CasertaCaserta, Italy.
Dipartimento di Scienze e Tecnologie, Università degli Studi del SannioBenevento, Italy.
Front Physiol. 2017 Sep 14;8:706. doi: 10.3389/fphys.2017.00706. eCollection 2017.
3,3',5-triiodo-L-thyronine (T3) improves hepatic lipid accumulation by increasing lipid catabolism but it also increases lipogenesis, which at first glance appears contradictory. Recent studies have shown that 3,5-diiodothyronine (T2), a natural thyroid hormone derivative, also has the capacity to stimulate hepatic lipid catabolism, however, little is known about its possible effects on lipogenic gene expression. Because genes classically involved in hepatic lipogenesis such as SPOT14, acetyl-CoA-carboxylase (ACC), and fatty acid synthase (FAS) contain thyroid hormone response elements (TREs), we studied their transcriptional regulation, focusing on TRE-mediated effects of T3 compared to T2 in rats receiving high-fat diet (HFD) for 1 week. HFD rats showed a marked lipid accumulation in the liver, which was significantly reduced upon simultaneous administration of either T3 or T2 with the diet. When administered to HFD rats, T2, in contrast with T3, markedly downregulated the expression of the above-mentioned genes. T2 downregulated expression of the transcription factors carbohydrate-response element-binding protein (ChREBP) and sterol regulatory element binding protein-1c (SREBP-1c) involved in activation of transcription of these genes, which explains the suppressed expression of their target genes involved in lipogenesis. T3, however, did not repress expression of the TRE-containing ChREBP gene but repressed SREBP-1c expression. Despite suppression of SREBP-1c expression by T3 (which can be explained by the presence of nTRE in its promoter), the target genes were not suppressed, but normalized to HFD reference levels or even upregulated (ACC), partly due to the presence of TREs on the promoters of these genes and partly to the lack of suppression of ChREBP. Thus, T2 and T3 probably act by different molecular mechanisms to achieve inhibition of hepatic lipid accumulation.
3,3',5-三碘-L-甲状腺原氨酸(T3)通过增加脂质分解代谢来改善肝脏脂质蓄积,但它也会增加脂肪生成,乍一看这似乎相互矛盾。最近的研究表明,天然甲状腺激素衍生物3,5-二碘甲状腺原氨酸(T2)也有刺激肝脏脂质分解代谢的能力,然而,关于其对脂肪生成基因表达可能产生的影响却知之甚少。由于经典参与肝脏脂肪生成的基因,如SPOT14、乙酰辅酶A羧化酶(ACC)和脂肪酸合酶(FAS)都含有甲状腺激素反应元件(TREs),我们研究了它们的转录调控,重点关注在接受高脂饮食(HFD)1周的大鼠中,与T2相比T3通过TRE介导的效应。HFD大鼠肝脏中出现明显的脂质蓄积,在饮食中同时给予T3或T2后,脂质蓄积显著减少。与T3相反,给HFD大鼠施用T2时,上述基因的表达明显下调。T2下调了参与这些基因转录激活的转录因子碳水化合物反应元件结合蛋白(ChREBP)和固醇调节元件结合蛋白-1c(SREBP-1c)的表达,这解释了其参与脂肪生成的靶基因表达受到抑制的原因。然而,T3并未抑制含TRE的ChREBP基因的表达,但抑制了SREBP-1c的表达。尽管T3抑制了SREBP-1c的表达(这可以通过其启动子中存在非典型TRE来解释),但靶基因并未受到抑制,而是恢复到HFD参考水平,甚至上调(ACC),部分原因是这些基因的启动子上存在TREs,部分原因是ChREBP未受到抑制。因此,T2和T3可能通过不同的分子机制来抑制肝脏脂质蓄积。